Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xuebin Tian, Xiangkuo Zheng, Yao Sun, Renchi Fang, Siqin Zhang, Xiucai Zhang, Jie Lin, Jianming Cao & Tieli Zhou. (2020) Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Escherichia
coli Isolated from Chinese Patients During 2002–2017. Infection and Drug Resistance 13, pages 501-512.
Read now
Read now
Articles from other publishers (20)
Tran Thi Dieu Thuy, Hsu-Feng Lu, Pei-Yun Kuo, Wei-Hung Lin, Tzu-Ping Lin, Yi-Tzu Lee, Tran Thi Thuy Duong, Ming-Cheng Wang, Yi-Hong Lee, Li-Li Wen, Yu-Chen Chen & Cheng-Yen Kao. (2022) Whole-genome-sequence-based characterization of an NDM-5-producing uropathogenic Escherichia coli EC1390. BMC Microbiology 22:1.
Crossref
Crossref
Nan Jing, Wenjuan Yan, Qi Zhang, Youhua Yuan, Xidian Wei, Wenmin Zhao, Shengqiang Guo, Limin Guo, Yuan Gao, Liang Zhao, Caiqin Shi & Yi Li. (2022) Epidemiology and genotypic characteristics of carbapenem resistant Enterobacterales in Henan, China: a multicentre study. Journal of Global Antimicrobial Resistance 29, pages 68-73.
Crossref
Crossref
Wan-Ting Yang, I-Ju Chiu, Yao-Ting Huang & Po-Yu Liu. (2022) Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli. Frontiers in Microbiology 13.
Crossref
Crossref
Dimard E. Foudraine, Camiel N. M. Aarents, Agnes A. Wattel, Ria van Boxtel, Nikolaos Strepis, Marian T. ten Kate, Annelies Verbon, Theo M. Luider, Corné H. W. Klaassen, John Hays, Lennard J. M. Dekker, Jan Tommassen & Wil H. F. Goessens. (2022) Liquid Chromatography-Tandem Mass Spectrometry Analysis Demonstrates a Decrease in Porins and Increase in CMY-2 β-Lactamases in Escherichia coli Exposed to Increasing Concentrations of Meropenem. Frontiers in Microbiology 13.
Crossref
Crossref
Yu-Tsung Huang, Yao-Wen Kuo, Nan-Yao Lee, Ni Tien, Chun-Hsing Liao, Lee-Jene Teng, Wen-Chien Ko & Po-Ren Hsueh. (2022)
Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
Enterobacterales
Isolates Associated with Bloodstream Infection
. Microbiology Spectrum 10:1.
Crossref
Crossref
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Hsian-Yu Wang, Sung-Pin Tseng & Po-Liang Lu. (2022) Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. Journal of Microbiology, Immunology and Infection 55:1, pages 86-94.
Crossref
Crossref
Gayashan Chathuranga, Thushari Dissanayake, Neluka Fernando & Chandanie Wanigatunge. (2021) Appropriateness of the Empirical Antibiotics Prescribed and Their Concordance with National Guidelines for Three Selected Infections among Cancer Patients in a Tertiary Care Centre in Sri Lanka. International Journal of Microbiology 2021, pages 1-7.
Crossref
Crossref
Pawarisa Terbtothakun, Ozioma Forstinus Nwabor, Thanyaluck Siriyong, Supayang P. Voravuthikunchai & Sarunyou Chusri. (2021) Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 and blaNDM-5. Antibiotics 10:8, pages 1023.
Crossref
Crossref
Ching-Hsun Wang, Ling Ma, Li-Yueh Huang, Kuo-Ming Yeh, Jung-Chung Lin, L. Kristopher Siu & Feng-Yee Chang. (2021) Molecular epidemiology and resistance patterns of blaOXA-48 Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan. Journal of Microbiology, Immunology and Infection 54:4, pages 665-672.
Crossref
Crossref
Brian D. Johnston, Paul Thuras, Stephen B. Porter, Melissa Anacker, Brittany VonBank, Paula Snippes Vagnone, Medora Witwer, Mariana Castanheira & James R. Johnson. (2021) Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002–2017). European Journal of Clinical Microbiology & Infectious Diseases.
Crossref
Crossref
Shu-Chen Kuo, Yung-Chih Wang, Mei-Chen Tan, Wei-Cheng Huang, Yih-Ru Shiau, Hui-Ying Wang, Jui-Fen Lai, I-Wen Huang & Tsai-Ling Lauderdale. (2021)
In vitro
activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
. Journal of Antimicrobial Chemotherapy 76:8, pages 2071-2078.
Crossref
Crossref
Chih-Cheng Lai & Wen-Liang Yu. (2021) Klebsiella pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution over 20 Years, 1998–2019. International Journal of Antimicrobial Agents 58:1, pages 106354.
Crossref
Crossref
Yu-Shan Huang, Wan-Chen Tsai, Jia-Jie Li, Pao-Yu Chen, Jann-Tay Wang, Ying-Tsong Chen, Feng-Jui Chen, Tsai-Ling Lauderdale & Shan-Chwen Chang. (2021) Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018. Scientific Reports 11:1.
Crossref
Crossref
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan-Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Yu-Tzu Lin, Sheng-Fan Wang, Sung-Pin Tseng & Po-Liang Lu. (2020) In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan. Microorganisms 8:12, pages 1981.
Crossref
Crossref
Ya-Ting Chang, Tsung-Ying Yang, Po-Liang Lu, Shang-Yi Lin, Liang-Chun Wang, Sheng-Fan Wang, Ya-Ju Hsieh & Sung-Pin Tseng. (2020) Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae. Microorganisms 8:12, pages 1964.
Crossref
Crossref
Jocelin Merida-Vieyra, Agustín De Colsa-Ranero, Yair Calderón-Castañeda & Alejandra Aquino-Andrade. (2020) Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
Wen-Chien Ko & Gregory G. Stone. (2020) In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017). Annals of Clinical Microbiology and Antimicrobials 19:1.
Crossref
Crossref
Ching-Hsun Wang, L. Kristopher Siu, Feng-Yee Chang, Yu-Kuo Tsai, Yi-Tsung Lin, Sheng-Kang Chiu, Li-Yueh Huang & Jung-Chung Lin. (2020)
A Novel Deletion Mutation in
pmrB
Contributes to Concurrent Colistin Resistance in Carbapenem-Resistant Escherichia coli Sequence Type 405 of Clinical Origin
. Antimicrobial Agents and Chemotherapy 64:6.
Crossref
Crossref
Dalal Hammoudi Halat & Carole Ayoub Moubareck. (2020) The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics 9:4, pages 186.
Crossref
Crossref
Guanghui Zheng, Yan Zhang, Lina Zhang, Lingye Qian, Yumeng Cai, Hong Lv, Xixiong Kang, Dawen Guo, Xiaoming Wang, Jing Huang, Zhixian Gao, Xiuru Guan & Guojun Zhang. (2020) Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study. Scientific Reports 10:1.
Crossref
Crossref